Navigation Links
Lung Cancer: Still the Biggest Cancer Killer, by Far
Date:12/27/2008

While researchers make advances, quitting smoking remains your best bet

SATURDAY, Dec. 27 (HealthDay News) -- It's the leading cause of cancer death in the United States, killing more people each year than breast, prostate, colon, liver, kidney and melanoma cancers combined.

It's typically discovered too late to be treated successfully, with about 85 percent of victims dead within five years of diagnosis.

And nine out of 10 cases of the disease are tied to a single behavior -- smoking.

Lung cancer killed 160,390 people in 2007, according to the Lung Cancer Alliance. That's an average of 439 people a day.

And tobacco caused 90 percent of those deaths, according to the U.S. National Cancer Institute.

"Smoking is the most lethal legal activity in our society," said Dr. James Mulshine, a professor of internal medicine and associate provost for research at Rush University Medical Center in Chicago.

Researchers are trying to find better ways to detect lung cancer and to find genetic warning signs, or markers, that could predict who might be at increased risk.

But doctors say anti-smoking measures have proven the only effective weapon against the disease.

"At this point, the progress in decreasing lung cancer death rates is due solely to men quitting smoking since the early 1990s," said Dr. Michael Thun, vice president of epidemiology and surveillance research for the American Cancer Society.

The death rate for men fell from 90.6 deaths per 100,000 people in 1990 to 69.4 deaths per 100,000 in 2005, Thun said. But the death rate for women peaked in 1998 at 41 deaths per 100,000 and has remained in that range ever since, he said.

"Lung cancer rates have been falling in men since 1991, since men began to quit smoking," Thun said. "They have leveled off in women, but are not declining. Women started smoking later than men in our society and are having more
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Intimacy and Sexuality After Cancer: Questions Answered and Concerns Addressed
2. News from Cancer: Disparities in head and neck cancer patients
3. New approach to cancer: Find most tightly controlled genes
4. With Prostate Cancer: Waiting for Symptoms Is Not an Option
5. Fighting Cancer: Historic Anti-Asbestos Legislation Moving Forward With Support of Meso Foundation
6. Stem cells and cancer: Scientists investigate a fine balancing act
7. A new way to fight cancer: the silver shield
8. Patrick Swayzes Diagnosis With Pancreatic Cancer: a Statement From the Pancreatic Cancer Action Network
9. Pancreatic cancer: The smaller the tumor, the better your chances, study shows
10. Mislabeled Supplement Spurred Prostate Cancer: Report
11. Mislabled Supplement Spurred Prostate Cancer: Report

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., , RED BANK, N.J., Dec. 1 /PRNewswire/ ...rs know breastfeeding is ideal for their babies an...o decide what works best for them and their famili...inr.mediaseed.tv/IFC_37156/ ,, The survey of m...d that most mothers (83%) made their infant feedin...
(Date:12/1/2009)...iscovery could aid in development of simple screen...1 (HealthDay News) -- In a finding that could lead... U.S. researchers have identified immune system ma...ple at high risk for lung cancer. , The researc...mples from 137 people with non-small cell lung ca...
(Date:12/1/2009)...DC urges H1N1 vaccination because pandemic,s cours.... 1 (HealthDay News) -- A U.S. health official sai... be on the wane nationally, but many experts agree...r. , The flu is now widespread in 32 states -- ... Frieden, director of the U.S. Centers for Disease...
(Date:12/1/2009)... Ever thought you could qu...! Kevin Arthur Smith,s groundbreaking new system f...y, permanent. In just twenty eight days your cravi... , (PRWEB) December 1, 20...uring her eight-year addiction to nicotine, smokin...
(Date:12/1/2009)..., , ,, NEW YORK, Dec. 1 /P...and a global leader in the development and deliver...for the medical, scientific and academic markets, ...versal Search, our first-to-market cross-platform ...sychology lexicon, based on the American Psycholog...
Breaking Medicine News(10 mins):Health News:VIDEO from Medialink and HealthyWomen: Breast, Bottle or Both? 2Health News:Gene 'Signature' May Point to Lung Cancer 2Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3
...ill, arsenic also can prolong the lives of patient...aturday found. "This study shows that even...arlier in the course of treatment," said Dr. Bayar...erican Society of Oncology (ASCO) which brought to...
...JAMA, has identified novel genetic mutations linke... that these mutations are due to both independent ...as been released early to coincide with its presen...is the second most common cause of cancer death wo...
...sburgh Medical Center (UPMC) study presented at th...al Oncology (ASCO) in Chicago and published as Abs...ted for follicular lymphoma, a slow-growing type o...to the treatment and since only a short-course of ...
...nounced follow-up data from a Phase 2 clinical tri...ch was conducted by the Johns Hopkins Sidney Kimme...ith operable pancreatic cancer who received GVAX a... to be 26.8 months, a result which compares favora...
...end, even if it is all subtle, as in Canada appare...e hard to pin down is more dangerous to mental hea...dy of 180 Korean immigrants living in Canada. ...lead author Samuel Noh, professor of psychiatry at...
...g of SNM, the world's largest society for molecula...man researchers stated that early metabolic imagin...ely identifies patients responding to chemotherapy...the treatment of common solid tumors," said Ken He...
Other Medicine News:Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 2Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 3Health News:Lymphoma Patients Maybe Helped by Adding Radioimmunotherapy to Chemo 2Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 2Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 3Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 4Health News:Koreans in Canada Feel Put Down by Subtle Racism 2Health News:Esophageal Cancer Patients' Positive Responses to Chemotherapy Accurately Identified by PET 2
(Date:12/1/2009)...TER, N.J., Dec. 1 Tibotec Therapeu...s, L.P., announced today that it is launching a ne...g women and people of color living with HIV/AIDS. ...ducational events, media outreach and a new Web si...g learnings from the GRACE study, the largest clin...
(Date:12/1/2009)...D CITY, Calif., Dec. 1 Codexis, In...p and the signing of its second agreement this yea...rld,s largest generic drug manufacturer. The new ...products. Codexis announced an earlier agreement ...ent, Teva will use Codexis biocatalysis technology...
(Date:12/1/2009)...STON, Dec. 1 An expert f...XL ), a leading global biopharmaceutical services ...ve approaches to drug development in Asia at the P...ence, being held December 1-3, 2009 at the Interco... of the conference, which is focused on maximizing...
Breaking Medicine Technology:Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 2Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 3Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 4Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 5Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 6Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 7Codexis Expands Collaboration with Teva 2PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 2PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 3PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 4What scientists know about jewel beetle shimmer 9338 1What scientists know about jewel beetle shimmer 9338 2R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 1R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 2R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 3R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 4R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 5R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 6R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 7R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 8Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 1Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 2Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 3
... (Nasdaq: CVTX ) announced today that eight abstr... anti-arrhythmia data from the MERLIN,TIMI-36 stud...pean Society,of Cardiology (ESC) Congress 2007 tak...007. A clinical trial update session entitled, Th... with Electrophysiologic Properties, on the,Incide...
...s, Inc. (Nasdaq: ADLS ), today announced the comm...stitute of Allergy and Infectious,Diseases (NIAID)...fense,research, under which the NIAID will conduct...te-stage antibiotic, as a treatment for,anthrax an...aboration is,part of the U.S. Government,s effort ...
Other Medicine Technology:CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007 2CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007 3Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 2Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 3Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 4
Lacrimal Cannula, Curved - Open End.
PremierEdge™ Implant Knives
Universal I/A handpiece - Titanium (Binkhorst Tip)
Universal I/A handpiece - Titanium (Curved Tip, Size: 16g Outer Cannula)
Medicine Products: